banner.png

Bio

About Aaron Neinstein, MD

Dr. Aaron Neinstein is Vice President of Digital Health at UCSF Health, Senior Director at the UCSF Center for Digital Health Innovation, and Associate Professor in the UCSF Division of Endocrinology, with a clinical practice focused on diabetes care. He is considered an expert in diabetes technology, including the use of insulin pumps and continuous glucose monitors, as a nationally-invited speaker and invited author to outlets like CNBC and Medscape, peer-reviewed author, and advisor to numerous companies. He was named by Marin Magazine to the Bay Area [415] Top Doctors List in 2020. In his clinical practice, he takes care of patients with diabetes as well as with disorders of the thyroid, adrenal, pituitary, ovaries, and testes, or other metabolic issues. (Note: If you are looking for a second opinion for an endocrine issue and are unable to come to UCSF, Dr. Neinstein can provide you a second opinion via UCSF’s online second opinion service.)

Dr. Neinstein is board certified in Endocrinology, Internal Medicine, and Clinical Informatics.  He was an inaugural inductee as a Fellow of the American Medical Informatics Association, and has focused his career on empowering patients and physicians to better access, share, understand, and use health information for more connected, collaborative care. He helped lead the Epic EHR implementation at UCSF and was on the founding team of Tidepool, a non-profit that creates open-source software to empower people with diabetes. At the UCSF CDHI, he leads a multi-disciplinary team focused on advancing interoperability and digital transformation of care delivery, including the use of telehealth and remote monitoring technologies to advance more connected care.

Disclosures

Links

Research Grants

  • Cisco Systems Inc (2016)

  • Commonwealth Fund (2018-2019)

Speaking Honoraria

  • UCSF CME

  • Academy Health (2018)

  • Symposia Medicus (2017)

Other

  • Maslon LLP

  • Elite Medical Experts

Consultant / Advisory Board (With Compensation)

  • Intuity Medical (2020-present)

  • Medtronic (2020-present)

  • Roche (2020-present)

  • Eli Lilly (2020-present)

  • Steady Health (2018-2021, acq. by Carbon Health)

  • HealthQuest Capital (2018)

  • Nokia Growth Partners (2017-2018)

  • WebMD/Medscape (2015-2019)

  • Grand Rounds (2014)

  • GLG (2014-present)

Consultant / Advisory Board (Without Compensation)

  • Philips (2021-present)

  • Tidepool (2012-present)